Aclarion, Inc. (NASDAQ:ACON) Sees Large Increase in Short Interest

Aclarion, Inc. (NASDAQ:ACON) was the recipient of a significant increase in short interest in the month of December. As of December 31st, there was short interest totalling 1,810,000 shares, an increase of 47.2% from the December 15th total of 1,230,000 shares. Currently, 17.4% of the shares of the company are sold short. Based on an average daily volume of 6,370,000 shares, the days-to-cover ratio is currently 0.3 days.

Analyst Ratings Changes

A number of analysts have weighed in on ACON shares. Maxim Group reissued a “hold” rating on shares of Aclarion in a report on Friday, December 13th. Ascendiant Capital Markets dropped their price objective on shares of Aclarion from $1.50 to $1.30 and set a “buy” rating on the stock in a research note on Wednesday, November 27th.

Aclarion Stock Performance

NASDAQ:ACON opened at $0.04 on Thursday. The business has a 50 day simple moving average of $0.16 and a 200 day simple moving average of $0.20. Aclarion has a 12-month low of $0.03 and a 12-month high of $3.85.

About Aclarion

Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software.